BlackRock Fund Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

BlackRock Fund Advisors’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$51K	Buy	251 +6	+2%	+$1.36K	﹤0.01%	3769
2016 Q3	$64K	Sell	245 -1	-0.4%	-$306	﹤0.01%	3715
2016 Q2	$73K	Buy	246 +93	+61%	+$32.7K	﹤0.01%	3743
2016 Q1	$65K	Sell	153 -11	-7%	-$4.12K	﹤0.01%	3761
2015 Q4	$81K	Buy	164 +10	+6%	+$7.22K	﹤0.01%	3782
2015 Q3	$180K	Buy	154 +35	+29%	+$53.6K	﹤0.01%	3512
2015 Q2	$209K	Buy	119 +15	+14%	+$23.3K	﹤0.01%	3514
2015 Q1	$122K	Buy	104 +40	+63%	+$47.4K	﹤0.01%	3589
2014 Q4	$64K	Buy	64 +36	+129%	+$36.1K	﹤0.01%	3656
2014 Q3	$38K	Buy	+28	New	+$40.1K	﹤0.01%	3733

Other funds holding VYNT

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

FCM

Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diker Management New York $130M AUM 97.77% 1-Year Est. Return

BlackRock Fund Advisors's VYNT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Vyant Bio, Inc. Common Stock (VYNT) stake by 2.4% in Q4 2016, buying an estimated $1.36K and bringing the position to 251 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #3769.

BlackRock Fund Advisors first reported a position in VYNT in Q3 2014 and has held it in 10 quarters since. The position peaked at $209K in Q2 2015. 29 funds tracked by Wall St. Rank hold VYNT as of Q4 2016.

BlackRock Fund Advisors held 251 shares of Vyant Bio, Inc. Common Stock worth $51K as of Q4 2016.
BlackRock Fund Advisors bought 6 Vyant Bio, Inc. Common Stock shares in Q4 2016, an estimated $1.36K.
Vyant Bio, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3769 holding.
BlackRock Fund Advisors first reported a position in Vyant Bio, Inc. Common Stock in Q3 2014 and has held it in 10 quarters since.
BlackRock Fund Advisors's Vyant Bio, Inc. Common Stock position peaked at $209K in Q2 2015.
29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.